Skip to main content
Veterinary Medicines

GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated

Product identification

Medicine name:
GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
Target species:
  • Chicken
Route of administration:
  • Coarse spray

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
    5.30
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Coarse spray
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 2000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 10 blisters.
  • 2000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 1 blister.
  • 1000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 10 blisters.
  • 1000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 1 blister.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/056/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."